Published in

Springer Nature [academic journals on nature.com], Blood Cancer Journal, 8(5), p. e341-e341, 2015

DOI: 10.1038/bcj.2015.48

Links

Tools

Export citation

Search in Google Scholar

Factors influencing extramedullary relapse after allogeneic transplantation for multiple myeloma

Journal article published in 2015 by Laure Vincent ORCID, Lu Zy, Patrice Ceballos, C. Plassot, Meniane Jc, J. C. Méniane, P. Quittet, Robert Navarro, C. Cyteval, V. Szablewski, Z. Y. Lu, T. Kanouni, Jérôme Moreaux, Guillaume Cartron ORCID, Bernard Klein and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Patients undergoing allogeneic stem cell transplantation (allo-SCT) with reduced intensity conditioning (RIC) for multiple myeloma (MM) experience a high frequency of extra-medullary relapses (EMR) (20–37%). 1–3 This study aims at determining factors predictive for EMR after allo-SCT, prognosis of EMR and efficacy of salvage therapies. We retrospectively analyzed a continuous cohort of 79 patients with MM who received allo-SCT in one single center (Montpellier University Hospital, France) between 2000 and 2010.